Clarithromycin Granules for Oral Suspension Clinical Experience in Patients with Non-Mycobacterial Infections

@inproceedings{2017ClarithromycinGF,
  title={Clarithromycin Granules for Oral Suspension Clinical Experience in Patients with Non-Mycobacterial Infections},
  author={},
  year={2017}
}
  • Published 2017
clarithromycin, followed by a four-week recovery period. No deaths occurred and no changes in the general condition of the animals were observed. Necropsy revealed no abnormalities. Upon histological examination, fatty deposition of centrilobular hepatocytes and cell infiltration of portal areas were observed by light microscopy, and an increase in hepatocellular fat droplets was noted by electron microscopy in the 300 mg/kg dose group. The toxic dose in juvenile beagle dogs was considered to… CONTINUE READING

Similar Papers

Loading similar papers…